|
"lin cy"的相关文件
显示项目 481-490 / 739 (共74页)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
每页显示[10|25|50]项目
| 臺北醫學大學 |
2010 |
USE OF OUTER MEMBRANE PROTEIN A (OMPA) IN TREATMENT/PREVENTION/DIAGNOSIS OF INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE AND OTHER GRAM-NEGATIVE BACTERIA
|
Yang, YY;Wu, HH;Leu, SJ;Shih, NY;Huang, IJ;Lin, CY |
| 亞洲大學 |
2009.05 |
添加米糠萃取物對胰島β-細胞的影響 (PA-39)
|
林佳育;LIN, CY |
| 國家衛生研究院 |
2009-12 |
PALM: a paralleled and integrated framework for phylogenetic inference with automatic likelihood model selectors
|
Chen, SH;Su, SY;Lo, CZ;Chen, KH;Huang, TJ;Kuo, BH;Lin, CY |
| 國立臺灣大學 |
2009-12 |
Histone Deacetylase 2 expression predicts poorer prognosis in oral cancer patients
|
Chang, HH; Chiang, CP; Hung, HC; Lin, CY; Kuo, YP |
| 國家衛生研究院 |
2009-11-11 |
Cloning, expression, and characterization of an enzyme possessing both glutaredoxin and dehydroascorbate reductase activity from taiwanofungus camphorata
|
Ken, CF;Lin, CY;Jiang, YC;Wen, L;Lin, CT |
| 中國醫藥大學 |
2009-10 |
Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells
|
陳素鳳(Chen, Su Feng); (Lin CY,); (Chang YC,); (Li JW,); (Fu E,); (Chang FN,); (Lin YL,); (Nieh S)* |
| 國家衛生研究院 |
2009-08-13 |
Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach
|
Wu, YS;Coumar, MS;Chang, JY;Sun, HY;Kuo, FM;Kuo, CC;Chen, YJ;Chang, CY;Hsiao, CL;Liou, JP;Chen, CP;Yao, HT;Chiang, YK;Tan, UK;Chen, CT;Chu, CY;Wu, SY;Yeh, TK;Lin, CY;Hsieh, HP |
| 亞洲大學 |
2009-08 |
Anticoagulatory, Antiinflammatory, and Antioxidative Effects of Protocatechuic Acid in Diabetic Mice
|
Lin, CY;Lin, Chia-Yu; Huang, CS;Huang, Chin-Shiu;Huang, CY;Huang, Chun-Yin;Yin, MC;Yin, Mei-Chin;林佳育;黃晉修 |
| 中國醫藥大學 |
2009-08 |
Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach.
|
(Wu YS); (Coumar MS); (Chang JY); (Sun HY); (Kuo FM); (Kuo CC); (Chen YJ); (Chang CY); (Hsiao CL); (Liou JP); (Chen CP); 姚賢宗(Hsien-Tsung Yao); (Chiang YK); (Tan UK); (Chen CT); (Chu CY); (Wu SY); (Yeh TK); (Lin CY); (Hsieh HP)* |
| 國家衛生研究院 |
2009-07-23 |
Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice
|
Wu, CH;Hung, MS;Song, JS;Yeh, TK;Chou, MC;Chu, CM;Jan, JJ;Hsieh, MT;Tseng, SL;Chang, CP;Hsieh, WP;Lin, Y;Yeh, YN;Chung, WL;Kuo, CW;Lin, CY;Shy, HS;Chao, YS;Shia, KS |
显示项目 481-490 / 739 (共74页)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
每页显示[10|25|50]项目
|
